ReviewMedicine and pharmacy reports2022

TXNIP inhibition in the treatment of diabetes. Verapamil as a novel therapeutic modality in diabetic patients.

Agnieszka Magdalena Borowiec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.